Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia. [electronic resource]
Producer: 20130924Description: 707-16 p. digitalISSN:- 1440-1746
- Adult
- Antiviral Agents -- economics
- Australia
- Cohort Studies
- Cost-Benefit Analysis
- Drug Therapy, Combination -- economics
- Early Medical Intervention
- Female
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon-alpha -- economics
- Male
- Markov Chains
- Models, Statistical
- Polyethylene Glycols -- economics
- Quality-Adjusted Life Years
- Recombinant Proteins -- economics
- Ribavirin -- economics
- Substance Abuse, Intravenous -- economics
- Victoria
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.